{ }
001122334455554433221100
001122334455554433221100

iqvia stock analysis shows mixed ratings and price target adjustments by analysts

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services across the life sciences sector, with institutional investors holding 89.62% of its stock. Recent analyst ratings show a "Moderate Buy" consensus, with price targets ranging from $250 to $276, despite a recent stock decline to $207.36. The company reported a quarterly EPS of $2.90, missing estimates, and has a market cap of $37.64 billion.

ubs lowers iqvia holdings price target but maintains buy rating

UBS has adjusted its price target for IQVIA Holdings Inc. to $255 from $260 while maintaining a Buy rating. The company excels in information, analytics, research, and healthcare services, with net sales primarily derived from contract research and clinical development (54.5%) and technology solutions (39.9%). Geographically, sales are distributed across the Americas (49.4%), Europe and Africa (31.4%), and Asia/Pacific (19.2%).

natural language processing market in healthcare projected to reach seven billion by 2028

The natural language processing (NLP) market in healthcare and life sciences is projected to grow from $2.56 billion in 2023 to $7.02 billion by 2028, driven by advancements in digital technology, telemedicine, and AI-driven personalized medicine. Key players include Google, Microsoft, and IBM, with trends highlighting the rise of conversational AI and real-time clinical NLP. The increasing adoption of electronic health records and virtual consultations further supports this growth trajectory.

iqvia holdings sees increased institutional investment amid mixed analyst ratings

IQVIA Holdings Inc. operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The company has seen significant institutional investment, with 89.62% of its stock owned by hedge funds and other investors. Analysts maintain a "Moderate Buy" rating, with a consensus price target of $256.50, despite recent adjustments to target prices by various firms.
11:22 30.11.2024

iqvia holdings inc maintains strong market position with diverse service offerings

Iqvia Holdings Inc. is a leading global provider of information, analytics, research, and healthcare services, primarily driven by technology solutions. Its net sales are derived from contract research and clinical development (54.5%), technology and analytical solutions (39.9%), and integrated services (5.6%). Geographically, sales are distributed across the Americas (49.4%), Europe and Africa (31.4%), and Asia/Pacific (19.2%).
16:09 01.11.2024

iqvia holdings inc maintains strong market position with diverse service offerings

Iqvia Holdings Inc. is a leading global provider of information, analytics, research, and healthcare services, primarily driven by technology solutions. Its net sales are derived from contract research and clinical development (54.5%), technology and analytical solutions (39.9%), and integrated services (5.6%). Geographically, sales are distributed across the Americas (49.4%), Europe and Africa (31.4%), and Asia/Pacific (19.2%).
16:09 01.11.2024

medical writing market growth driven by demand for accurate health information

Medical journalism has emerged as the leading segment in the medical writing market, driven by the public's demand for reliable health information and the rise of online platforms. North America holds a significant market share due to its robust pharmaceutical industry and regulatory frameworks, while the global market is projected to grow from $3.15 billion in 2022 to $7.95 billion by 2032, at a CAGR of 9.7%. The clinical writing segment is crucial, accounting for 36.8% of the market, reflecting the increasing number of clinical trials and stringent regulatory requirements.

exponential growth anticipated in healthcare information technology consulting market through 2032

Vantage Market Research reports significant growth in the Healthcare Information Technology Consulting Market, driven by increasing demand and opportunities. The comprehensive analysis includes market size, trends, and competitive landscape, providing insights for decision-makers to enhance business strategies. Key players include IBM, Deloitte, and Oracle, with a focus on customized consulting services to meet specific client needs.

tryon medical partners teams up with private equity to expand services

Tryon Medical Partners, Charlotte's largest independent physician practice, has partnered with private equity firm TPG to enhance operations and meet rising patient demand. Despite concerns about private equity's impact on healthcare, Tryon’s CEO assures that clinical control remains with physicians, emphasizing a commitment to quality care at competitive prices. The deal reflects a broader trend of physician practices seeking private equity investment to navigate a challenging healthcare landscape dominated by large hospital systems.

de-identified health data market trends and innovations shaping clinical research

The de-identified health data market is projected to grow at a CAGR of 9.0% from 2024 to 2030, driven by increasing demand from healthcare providers and pharmaceutical companies for research and drug development. Key players include IQVIA, Oracle, and Veradigm, with recent collaborations enhancing data utilization in clinical trials and precision medicine. North America leads the market, benefiting from advanced healthcare infrastructure and stringent data privacy regulations.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.